IGP DISU DEPLOYS COMMISSIONERS OF POLICE TO COMMANDS, STRATEGIC FORMATIONS. (PHOTO). #PRESS RELEASE.
Moderna said on Tuesday that it had begun its first human trial of an experimental vaccine to protect against Bundibugyo ebolavirus, a strain of Ebola that has killed more than 1,700 people so far and currently has no approved vaccine.
Health Canada has cleared an early-stage study and the first volunteers have already received the shot, called mRNA-1469, according to the vaccine maker. The experimental shot uses the same mRNA technology behind Moderna's COVID-19 vaccine.
The trial, which will run at three sites in Canada, aims to enroll about 80 healthy adults to check if the vaccine is safe and triggers an immune response, Reuters reported.
The work is part of an expanded partnership with the Coalition for Epidemic Preparedness Innovations, or CEPI, which has pledged up to $50 million to help fund the vaccine's early testing and manufacturing.
Comments
Post a Comment